Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 12, Issue 3
|
pp. 2246–2260
The protein tyrosine kinase inhibitor, Genistein, delays intervertebral disc degeneration in rats by inhibiting the p38 pathway-mediated inflammatory response
Back to article
Figure 2
(2 of 7)
−
100%
+
Figure 2.
IL-1β treatment reduces NPC viability.
(
A
) Viability of NPCs treated with IL-1β. *p<0.05 (
B
) Viability of NPCs treated with IL-1β and Genistein. *p<0.05.